Prime Medicine, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Prime Medicine, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q2 2024.
  • Prime Medicine, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$134K, a 532% decline year-over-year.
  • Prime Medicine, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$108K, a 25.5% increase year-over-year.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2023 was -$279K, a 70.6% increase from 2022.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2022 was -$948K, a 95.1% decline from 2021.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2021 was -$486K, a 126% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$108K -$134K -$165K -532% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $57K $134K +$336K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$279K $0 +$186K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 -$465K -$108K -$320K -151% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$145K $31K +$473K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$618K -$202K +$330K +62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$948K -$186K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $212K +$2.58M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$442K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$532K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$2.37M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.